ALBANY, N.Y. (AP) — Two couples are suing a New York fertility doctor and his clinic after giving birth to children with a genetic abnormality later traced back to donated eggs.The two children, both born in 2009, have Fragile X syndrome, a genetic condition that can lead to intellectual and developmental impairments. The parents, identified by initials and last names in legal papers, argue the doctor and the clinic failed to test the women who donated the eggs to determine whether they were carriers for Fragile X. They're seeking damages for the added expenses of raising a disabled child.The New York Court of Appeals heard oral arguments in the case on Wednesday. A decision is expected next year.
NYS Entity Status
NYS Filing Date
MAY 14, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2014 - GREG LOWDER, PHD, CLINICAL PSYCHOLOGIST, P.C.
Around the Web
- Couples sue fertility clinic over eggs with genetic defect
By DAVID KLEPPER, Associated Press - Wednesday Nov 15, 2017
- How a sports psychologist has made one Net a better player
By Brian Lewis - Saturday Oct 14, 2017
Rondae Hollis-Jefferson has clearly matured from last season, learned not to let one bad play compound into a bad quarter or a bad game. And according to the young Nets forward, it has helped to not talk to just teammates, but the team psychologist as well. “Last season, yeah, I feel like I held onto...
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]
- Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another
By Frank Vinluan - Monday Nov 20, 2017
Acorda Therapeutics said Monday that it will stop work on an experimental treatment for Parkinson’s disease, spelling the end for a drug the Ardsley, NY, company added to its pipeline last year in a $363 million deal. The announcement follows the recent emergence of safety problems for the Acorda (NASDAQ: ACOR) drug, tozadenant. Acorda said […]
- Sun Valley bakery is popular among techies of Silicon Valley
By Richard Morgan - Saturday Jul 15, 2017
Sun Valley’s Konditorei (German for bakery) central to Allen & Co. conference attendees, has gotten so culinary PC it could open a Silicon Valley outpost. Sun Valley Lodge executive chef Derek Gallegos recently completed the menu makeover, balancing Konditorei’s Austrian-inspired specialties with such local offerings as an Idaho Ruby Trout Sandwich. Manager Greg Van hoozer...
- Greg Norman, Verizon are betting big on new golf technology
By Post Staff Report - Monday Oct 2, 2017
Greg Norman, the Australian golf legend — aka The Shark — is very bullish on the future of golf in spite of the $70 billion industry’s challenges. He’s about to announce a big investment with Verizon in New York next month that he says will be a game-changer for golf, and bring innovation and technology...